Cancer is one of the deadliest and most difficult diseases to take control of, even in the modern era. As a result of this, research is always evolving but getting data is a very crucial aspect.
According to individuals like Eric Lefkofsky, more data on cancer is the one thing that is missing from the medical research system of the modern era because is how caner can be treated successfully. It is a known fact that there is tons and tons of patient data that is available but few if any sources that can combine that data with any genomic cancer information.
At the Fortune Brainstorm Health conference in San Diego, Lefkofsky stated that in addition to gathering molecular data, clinical data is also needed, like therapeutic and outcome response data. This means that not only is a patient’s DNA and RNA necessary but so are the kind of treatments that are used on patients and how they react to them. He specifically mentioned breast cancer and how certain treatments of patients can work for some patients but not the others, with variables such as if the patient is using other drugs.
Eric Lefkofsky is the CEO and co-founder of a group called Tempus, which is a technology company that is geared towards battling cancer using a special operating system. The goal of this was to enhance how electronic medial records (EMR) function by allowing it aggregate more patient data. Before founding the company, Lefkokfsy attended the University of Michigan and graduated with his Juris Doctor degree later on at the Michigan Law School. He has also served as an adjunct professor at the University of Chicago later on in life.
Upon the completion of college career, Lefkofsky founded the Lefkofsky Family Foundation in 2006, which was meant to create high-impact initiatives for sickness and serve the local communities. He has also been behind the creation of other projects such as being the chairman and co-founder of Groupon, a global marketplace that deals with commerce. He is also a founding partner for Lifebank which is a funding group specializing in technological advancement.
for details: www.tempus.com/about-us/